. 2019 Mar;20(3).
doi: 10.1016/S1470-2045(19)30026-9.

Immunotherapy and targeted therapy combinations in metastatic breast cancer

Francisco J Esteva 1 Vanessa M Hubbard-Lucey 2 Jun Tang 2 Lajos Pusztai 3 
  • PMID: 30842061
  •     32 citations


Immunotherapy is emerging as a new treatment modality in breast cancer. After long-standing use of endocrine therapy and targeted biological therapy, improved understanding of immune evasion by cancer cells and the discovery of selective immune checkpoint inhibitors have created novel opportunities for treatment. Single-drug therapies with monoclonal antibodies against programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) have shown little efficacy in patients with metastatic breast cancer, in part because of the low number of tumour-infiltrating lymphocytes in most breast cancers. There is growing interest in the development of combinations of immunotherapy and molecularly targeted therapies for metastatic breast cancer. In this Personal View, we review the available data and ongoing efforts to establish the safety and efficacy of immunotherapeutic approaches in combination with HER2-targeted therapy, inhibitors of cyclin-dependent kinases 4 and 6, angiogenesis inhibitors, poly(ADP-ribose) polymerase inhibitors, as well as chemotherapy and radiotherapy.

Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
Maria Laura De Angelis, Federica Francescangeli, Ann Zeuner.
Cancers (Basel), 2019 Oct 18; 11(10). PMID: 31619007    Free PMC article.
Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.
Fang Bai, Yuchun Jin, +5 authors, Kejin Wu.
Aging (Albany NY), 2019 Nov 13; 11(21). PMID: 31715586    Free PMC article.
Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment.
María José Godoy-Calderón, Eglys González-Marcano, Jeismar Carballo, Ana Federica Convit.
Oncotarget, 2019 Nov 26; 10(61). PMID: 31762937    Free PMC article.
Association Between Metabolic Syndrome and Breast Cancer Risk: An Updated Meta-Analysis of Follow-Up Studies.
Meng Guo, Tingting Liu, +7 authors, Ruopeng Zhang.
Front Oncol, 2019 Dec 12; 9. PMID: 31824862    Free PMC article.
Systematic Review.
A comprehensive, multidisciplinary, precision medicine approach to discover effective therapy for an undiagnosed, progressive, fibroinflammatory disease.
Bernadette R Gochuico, Shira G Ziegler, +7 authors, May C V Malicdan.
Transl Res, 2019 Sep 15; 215. PMID: 31520587    Free PMC article.
Transcriptome Analysis Reveals Key Genes and Pathways Associated with Metastasis in Breast Cancer.
Wei Li, Jianling Liu, +3 authors, Wenrong Xu.
Onco Targets Ther, 2020 Feb 06; 13. PMID: 32021278    Free PMC article.
Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis.
Yi-Jun Kim, So-Youn Jung, Kyubo Kim.
Sci Rep, 2019 Jun 14; 9(1). PMID: 31189932    Free PMC article.
Prospects for combining immune checkpoint blockade with PARP inhibition.
Anping Li, Ming Yi, +3 authors, Kongming Wu.
J Hematol Oncol, 2019 Sep 16; 12(1). PMID: 31521196    Free PMC article.
Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer.
Bei Li, Rongxin Geng, +5 authors, Shengrong Sun.
Front Oncol, 2020 Apr 01; 10. PMID: 32226776    Free PMC article.
Potential Applications of NRF2 Modulators in Cancer Therapy.
Emiliano Panieri, Aleksandra Buha, +8 authors, Luciano Saso.
Antioxidants (Basel), 2020 Feb 29; 9(3). PMID: 32106613    Free PMC article.
Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models.
Regina Padmanabhan, Hadeel Shafeeq Kheraldine, +2 authors, Ala-Eddin Al Moustafa.
Cancers (Basel), 2020 Mar 14; 12(3). PMID: 32164163    Free PMC article.
Relationship between IL-10 and PD-L1 in esophageal carcinoma tissues and IL-10 down-regulates PD-L1 expression via Met signaling pathway.
Qian Qian, Changping Wu, Jianping Chen, Weibing Wang.
J Gastrointest Oncol, 2020 May 14; 11(2). PMID: 32399275    Free PMC article.
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Zuzana Kos, Elvire Roblin, +91 authors, International Immuno-Oncology Biomarker Working Group.
NPJ Breast Cancer, 2020 May 16; 6. PMID: 32411819    Free PMC article.
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors.
Patrizia Vici, Laura Pizzuti, +3 authors, Maddalena Barba.
Immunotherapy, 2020 Jun 04; 12(10). PMID: 32489118    Free PMC article.
Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition.
Lauren E Stopfer, Joshua M Mesfin, +2 authors, Forest M White.
Nat Commun, 2020 Jun 04; 11(1). PMID: 32488085    Free PMC article.
All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon Responses and Antigen Presentation in Breast-Cancer Cells.
Marco Bolis, Gabriela Paroni, +11 authors, Enrico Garattini.
Cancers (Basel), 2020 May 10; 12(5). PMID: 32384653    Free PMC article.
Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer.
Hua Ge, Yan Yan, +2 authors, Kun Mao.
Med Sci Monit, 2020 Jun 21; 26. PMID: 32562536    Free PMC article.
Relationship between IL10 and PD-L1 in Liver Hepatocellular Carcinoma Tissue and Cell Lines.
Qian Qian, Changping Wu, Jianping Chen, Weibing Wang.
Biomed Res Int, 2020 Jul 30; 2020. PMID: 32724815    Free PMC article.
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers.
Tess O'Meara, Michal Marczyk, +6 authors, Lajos Pusztai.
JCO Precis Oncol, 2020 Sep 15; 4. PMID: 32923897    Free PMC article.
Innovative approaches to immunotherapy in breast cancer.
Kylie M Quinn.
J Thorac Dis, 2020 Sep 19; 12(8). PMID: 32944370    Free PMC article.
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance.
Maria Laura De Angelis, Federica Francescangeli, Filippo La Torre, Ann Zeuner.
Front Oncol, 2019 Jul 30; 9. PMID: 31355143    Free PMC article.
Highly Cited. Review.
LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer.
Cinzia Solinas, Edoardo Migliori, Pushpamali De Silva, Karen Willard-Gallo.
Cancers (Basel), 2019 Aug 23; 11(8). PMID: 31434339    Free PMC article.
Triple-negative breast cancer: current perspective on the evolving therapeutic landscape.
Joe Mehanna, Fady Gh Haddad, +2 authors, Hampig Raphael Kourie.
Int J Womens Health, 2019 Aug 27; 11. PMID: 31447592    Free PMC article.
The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype.
Satu Tiainen, Kirsi Rilla, +2 authors, Päivi Auvinen.
Breast Cancer Res Treat, 2020 Sep 20;. PMID: 32948994    Free PMC article.
Long-Lasting Response after Pembrolizumab in a Patient with Metastatic Triple-Negative Breast Cancer.
Paloma Peinado, Carmen Ramírez, +5 authors, Fernando Moreno.
Breast Care (Basel), 2020 Sep 29; 15(4). PMID: 32982655    Free PMC article.
MKL1 Mediates TGF-β Induced RhoJ Transcription to Promote Breast Cancer Cell Migration and Invasion.
Baoyu Chen, Yibiao Yuan, +4 authors, Yong Xu.
Front Cell Dev Biol, 2020 Sep 29; 8. PMID: 32984327    Free PMC article.
Chloride intracellular channel protein 2: prognostic marker and correlation with PD-1/PD-L1 in breast cancer.
Tao Xu, Zhi Wang, +3 authors, Xingrui Li.
Aging (Albany NY), 2020 Sep 12; 12(17). PMID: 32915772    Free PMC article.
A Tumor-Immune Interaction Model for Synergistic Combinations of Anti PD-L1 and Ionizing Irradiation Treatment.
Jong Hyuk Byun, In-Soo Yoon, +2 authors, Il Hyo Jung.
Pharmaceutics, 2020 Sep 04; 12(9). PMID: 32878065    Free PMC article.
Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists.
Alice Y Ho, Jean L Wright, +19 authors, Gaorav P Gupta.
Int J Radiat Oncol Biol Phys, 2020 May 18; 108(1). PMID: 32417409    Free PMC article.
Rho-associated protein kinase-dependent moesin phosphorylation is required for PD-L1 stabilization in breast cancer.
Fanbiao Meng, Yang Su, Bo Xu.
Mol Oncol, 2020 Sep 18;. PMID: 32941674    Free PMC article.
Expression of TRPC1 and SBEM protein in breast cancer tissue and its relationship with clinicopathological features and prognosis of patients.
Yongqing Zhang, Xiaoqin Lun, Weiling Guo.
Oncol Lett, 2020 Nov 17; 20(6). PMID: 33193852    Free PMC article.
Resistance and Overcoming Resistance in Breast Cancer.
Andrea Luque-Bolivar, Erika Pérez-Mora, Victoria Eugenia Villegas, Milena Rondón-Lagos.
Breast Cancer (Dove Med Press), 2020 Nov 19; 12. PMID: 33204149    Free PMC article.